Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T Cell-mediated Acute Graft Rejection

NCT02382211 is registered in ClinicalTrials.gov with Oxford Immunotec as lead sponsor.

NCT NCT02382211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02382211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T Cell-mediated Acute Graft Rejection
Lead sponsor
Oxford Immunotec
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
September 30, 2017
Enrollment
600 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

infection in solid organ transplant recipients